HIM
MRNA icon

Hillhouse Investment Management’s Moderna MRNA Stock Holding History

Hillhouse Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$14.3M Hold
978,434
– – 0.46% 26
2019
Q1 		$19.9M Hold
978,434
– – 0.83% 19
2018
Q4 		$14.9M Buy
+978,434
New +$16.1M 1.12% 11

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RWA
Ropes Wealth Advisors Boston, Massachusetts $515M AUM 21.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Hillhouse Investment Management's MRNA Position: Q2 2019 in Review

Hillhouse Investment Management held its Moderna (MRNA) position steady in Q2 2019 at 978,434 shares worth $14.3M. The position accounts for 0.46% of the portfolio, ranked #26.

Hillhouse Investment Management first reported a position in MRNA in Q4 2018 and has held it in 3 quarters since. The position peaked at $19.9M in Q1 2019. 138 funds tracked by Wall St. Rank hold MRNA as of Q2 2019.

  • Hillhouse Investment Management held 978,434 shares of Moderna worth $14.3M as of Q2 2019.
  • Hillhouse Investment Management left its Moderna share count unchanged in Q2 2019.
  • Moderna made up 0.46% of Hillhouse Investment Management's portfolio in Q2 2019, its #26 holding.
  • Hillhouse Investment Management first reported a position in Moderna in Q4 2018 and has held it in 3 quarters since.
  • Hillhouse Investment Management's Moderna position peaked at $19.9M in Q1 2019.
  • 138 funds tracked by Wall St. Rank held Moderna as of Q2 2019.

Based on Hillhouse Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.